These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 10576043

  • 61. Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation.
    Marcén R, Galeano C, Fernández-Rodriguez A, Jiménez-Alvaro S, Teruel JL, Rivera M, Burgos FJ, Quereda C.
    Transplant Proc; 2010 Oct; 42(8):3055-7. PubMed ID: 20970609
    [Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. Tacrolimus vs CyA Neoral in combination with MMF and steroids after cadaveric renal transplantation.
    Wang XH, Tang XD, Xu D.
    Transplant Proc; 2000 Nov; 32(7):1702-3. PubMed ID: 11119899
    [No Abstract] [Full Text] [Related]

  • 65. Early conversion from cyclosporine to tacrolimus increases renal graft function in chronic allograft nephropathy at BANFF stages I and II.
    Marcard T, Ivens K, Grabensee B, Willers R, Helmchen U, Rump LC, Blume C.
    Transpl Int; 2008 Dec; 21(12):1153-62. PubMed ID: 18684111
    [Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. A large, multicentre trial to compare the efficacy and safety of tacrolimus with cyclosporine microemulsion following renal transplantation.
    Sperschneider H, European Renal Transplantation Study Group.
    Transplant Proc; 2001 Dec; 33(1-2):1279-81. PubMed ID: 11267291
    [No Abstract] [Full Text] [Related]

  • 70. Calcineurin inhibitors in pediatric renal transplant recipients.
    Filler G.
    Paediatr Drugs; 2007 Dec; 9(3):165-74. PubMed ID: 17523697
    [Abstract] [Full Text] [Related]

  • 71. Complete response to tacrolimus in a child with severe aplastic anemia resistant to cyclosporin A.
    Macartney C, Freilich M, Odame I, Charpentier K, Dror Y.
    Pediatr Blood Cancer; 2009 Apr; 52(4):525-7. PubMed ID: 19058202
    [Abstract] [Full Text] [Related]

  • 72. Tacrolimus (FK 506) in kidney transplantation.
    Vanrenterghem Y.
    Transplant Proc; 1998 Aug; 30(5):2171-3. PubMed ID: 9723431
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. Conversion from cyclosporine to tacrolimus in pediatric kidney transplant recipients.
    Ferraresso M, Ghio L, Edefonti A, Garavaglia R, Berardinelli L.
    Pediatr Nephrol; 2002 Aug; 17(8):664-7. PubMed ID: 12185478
    [Abstract] [Full Text] [Related]

  • 77. Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection.
    Boratyńska M, Banasik M, Patrzałek D, Klinger M.
    Ann Transplant; 2006 Aug; 11(2):51-6. PubMed ID: 17494290
    [Abstract] [Full Text] [Related]

  • 78. GCF and serum myeloperoxidase and matrix metalloproteinase-13 levels in renal transplant patients.
    Emingil G, Afacan B, Tervahartiala T, Töz H, Atilla G, Sorsa T.
    Arch Oral Biol; 2010 Oct; 55(10):719-27. PubMed ID: 20637451
    [Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80. Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation.
    MacDonald AS.
    Transplant Proc; 2003 May; 35(3 Suppl):201S-208S. PubMed ID: 12742497
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.